Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : pharmacokinetics
Harbour BioMed Reports Positive Phase I Results for HBM9378 Antibody Therapy
03/23/2026 | Companies
antibody therapeutics,
biologics,
biotech innovation,
chronic obstructive pulmonary disease,
clinical research,
COPD,
drug development,
half-life extension,
Harbour BioMed,
HBM9378,
immune-oncology,
immunological disorders,
immunology,
Kelun-Biotech,
monoclonal antibody,
pharmacokinetics,
Phase I clinical trial,
respiratory medicine,
safety profile,
severe asthma,
SKB378,
TSLP inhibitor,
WIN378
Foresee Pharmaceuticals Reports Positive DSMB Review for Casppian Phase 3 CPP Trial
02/04/2026 | Companies
biopharmaceutical research,
CAMCEVI,
Casppian Phase 3,
central precocious puberty,
clinical trial update,
controlled-release formulation,
CPP,
Data and Safety Monitoring Board,
drug safety,
DSMB safety review,
Foresee Pharmaceuticals,
FP-001,
GnRH therapy,
leuprolide 42 mg,
long-acting injectable,
multinational clinical trial,
pediatric drug development,
pediatric endocrinology,
pharmacokinetics,
Phase 3 study,
prostate cancer treatment,
regulatory milestone
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com